Search results
Results from the WOW.Com Content Network
The tables below contain a sample list of benzodiazepines and benzodiazepine analogs that are commonly prescribed, with their basic pharmacological characteristics, such as half-life and equivalent doses to other benzodiazepines, also listed, along with their trade names and primary uses.
The ClearRx bottle design was created to replace the classic orange pill bottle, which had existed since just after World War II.Patients often did not read the information on the orange bottle label, as the text was tiny, and the company logo was usually the most emphasized text on the bottle.
The active ingredient was changed when the product was renamed in 1959, to be the laxative bisacodyl; the original active ingredients were purported to be 1 ⁄ 4 grain (16 mg) of aloe and 0.062 grains (4.0 mg) podophyllum resin. [3]
Human. Secobarbital is used in assisted dying, either euthanasia or palliative sedation. [8] [9] [10]In the Netherlands, individuals have two options for assisted dying: they can orally consume 100 mL of concentrated syrup containing either 15 grams of pentobarbital or 15 grams of secobarbital, or they can choose to have 2 grams of thiopental or 1 gram of propofol administered intravenously by ...
2C-I, also known as 2,5-dimethoxy-4-iodophenethylamine, is a phenethylamine of the 2C family with psychedelic effects. [1] It was first synthesized by Alexander Shulgin , and is described in Shulgin's book PiHKAL (1991).
The super-sleek fold-up case has not one but two locks to keep your meds from spilling out.
ALD-52, also known as 1-acetyl-LSD, is a psychedelic drug that is structurally similar to lysergic acid diethylamide (LSD). [3] ALD-52 has been reported to produce similar psychoactive effects as LSD, [3] but its pharmacological effects on humans are poorly understood.
2C-B (4-bromo-2,5-dimethoxyphenethylamine), also known as Nexus, is a synthetic psychedelic drug of the 2C family, mainly used as a recreational drug. [2] [1] [4] It was first synthesized by Alexander Shulgin in 1974 for use in psychotherapy.